EFM
E Fund Management Portfolio holdings
AUM
$2.1B
This Quarter Return
+1.57%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$1.61B
AUM Growth
+$36.4M
(+2.3%)
Cap. Flow
+$105M
Cap. Flow
% of AUM
6.47%
Top 10 Holdings %
Top 10 Hldgs %
61.46%
Holding
387
New
81
Increased
131
Reduced
147
Closed
19
Top Buys
| 1 |
ASE Group
ASX
|
$25.3M |
| 2 |
Microsoft
MSFT
|
$12.9M |
| 3 |
NVIDIA
NVDA
|
$11.9M |
| 4 |
Apple
AAPL
|
$9.18M |
| 5 |
Amazon
AMZN
|
$7.47M |
Top Sells
| 1 |
Sea Limited
SE
|
$24.3M |
| 2 |
Advanced Micro Devices
AMD
|
$16.8M |
| 3 |
TSMC
TSM
|
$8M |
| 4 |
Weibo
WB
|
$2.43M |
| 5 |
Pinduoduo
PDD
|
$2.4M |
Sector Composition
| 1 | Consumer Discretionary | 40.2% |
| 2 | Technology | 29.79% |
| 3 | Communication Services | 9.9% |
| 4 | Healthcare | 5.71% |
| 5 | Real Estate | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
HP
HPQ
$26.8B
| $218K | 0.01% |
7,212
-35
| -0.5% | -$1.06K |
|
327
Travere Therapeutics
TVTX
$1.75B
| $217K | 0.01% |
28,128
+5,218
| +23% | +$40.2K |
|
328
MongoDB
MDB
$25.5B
| $217K | 0.01% |
604
-2,126
| -78% | -$762K |
|
329
Philip Morris
PM
$254B
| $215K | 0.01% |
2,348
-99
| -4% | -$9.07K |
|
330
Soleno Therapeutics
SLNO
$3.56B
| $215K | 0.01% |
+5,016
| New | +$215K |
|
331
ADMA Biologics
ADMA
$4.03B
| $213K | 0.01% |
32,241
+3,181
| +11% | +$21K |
|
332
Corning
GLW
$59.4B
| $213K | 0.01% |
+6,456
| New | +$213K |
|
333
Cardinal Health
CAH
$36B
| $212K | 0.01% |
+1,895
| New | +$212K |
|
334
Quest Diagnostics
DGX
$20.1B
| $212K | 0.01% |
+1,593
| New | +$212K |
|
335
Vir Biotechnology
VIR
$765M
| $210K | 0.01% |
20,761
-664
| -3% | -$6.73K |
|
336
Apogee Therapeutics
APGE
$2.27B
| $208K | 0.01% |
+3,125
| New | +$208K |
|
337
Cooper Companies
COO
$13.3B
| $207K | 0.01% |
+2,038
| New | +$207K |
|
338
S&P Global
SPGI
$165B
| $207K | 0.01% |
+486
| New | +$207K |
|
339
Steris
STE
$23.9B
| $207K | 0.01% |
+919
| New | +$207K |
|
340
Hologic
HOLX
$14.7B
| $207K | 0.01% |
+2,649
| New | +$207K |
|
341
Goldman Sachs
GS
$221B
| $206K | 0.01% |
+493
| New | +$206K |
|
342
Labcorp
LH
$22.8B
| $206K | 0.01% |
+942
| New | +$206K |
|
343
Baxter International
BAX
$12.1B
| $205K | 0.01% |
+4,788
| New | +$205K |
|
344
Universal Health Services
UHS
$11.6B
| $205K | 0.01% |
+1,121
| New | +$205K |
|
345
Warner Bros
WBD
$29.5B
| $204K | 0.01% |
23,403
-580
| -2% | -$5.06K |
|
346
Waters Corp
WAT
$17.3B
| $201K | 0.01% |
+585
| New | +$201K |
|
347
Charles River Laboratories
CRL
$7.99B
| $200K | 0.01% |
+739
| New | +$200K |
|
348
Viatris
VTRS
$12.3B
| $197K | 0.01% |
16,487
-75
| -0.5% | -$896 |
|
349
AT&T
T
$208B
| $190K | 0.01% |
+10,815
| New | +$190K |
|
350
Hewlett Packard
HPE
$29.9B
| $188K | 0.01% |
10,576
-339
| -3% | -$6.01K |
|